Filing Flows › Utah Medical Products (UTMD) › Q2 2026
Utah Medical Products (UTMD) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 12, 2026
Utah Medical Products (UTMD) reported revenue of $8.5M for the second quarter 2026 (Q2 2026), -14% from a year earlier and -2% from the quarter before. Operating margin was 31.1%, net earnings $2.7M (31.5% of revenue).
Utah Medical Products, Q2 2026: revenue $8.5M (-14% year over year), operating margin 31.1%, net earnings $2.7M, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.5M | -2% | -14% |
| Gross profit | $4.8M | -10% | -15% |
| Operating profit | $2.6M | +3% | -17% |
| Net earnings | $2.7M | +3% | -12% |
| Operating cash flow | $1.4M | -56% | -52% |
| Free cash flow | $1.2M | -58% | -56% |
What changed
Revenue was $8.5M in Q2 2026, down 14% year over year and down 2% from the previous quarter. Gynecology/Electrosurgery/Urology was the largest line at 50% of revenue.
Gross margin was 55.8%, down 0.4 points from Q2 2025. Operating profit was $2.6M, a 31.1% margin (down 1.1 points year over year). Operating expenses fell 12% while revenue fell 14%. The fastest-growing cost line was Research & development (+14%). Net earnings were $2.7M, down 12% year over year. The effective tax rate was 18.3%.
Operating cash flow was $1.4M (down 52% year over year), 51% of net earnings. Non-cash charges added back $226K of depreciation and amortization and $72K of share-based compensation. Working capital and other items used $1.6M. Capital expenditures of $134K left free cash flow of $1.2M.
Questions
What was Utah Medical Products' revenue in the second quarter 2026?
Utah Medical Products (UTMD) reported revenue of $8.5M for the second quarter 2026 (Q2 2026), -14% from a year earlier and -2% from the quarter before.
Was Utah Medical Products profitable in the second quarter 2026?
Operating profit was $2.6M (31.1% of revenue) and net earnings $2.7M.